Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 922, pseudogene (RNU6-922P) is classified as a pseudogene located on human chromosome 3[1][3][5]. Unlike functional genes, pseudogenes such as RNU6-922P do not encode functional proteins and typically arise via gene duplication or retrotransposition events, accumulating disabling mutations over time[4]. The parental U6 small nuclear RNA (snRNA) is a core component of the spliceosome complex and essential for pre-mRNA splicing, but the RNU6-922P pseudogene itself is non-functional and is not reported to serve as a drug target[6][1]. While some pseudogenes in the genome may exert regulatory effects (e.g., as competing endogenous RNAs or miRNA sponges), there is no current evidence or literature associating RNU6-922P with functional regulatory activity or a disease phenotype[4]. Its presence is best understood as a non-functional remnant of the U6 snRNA gene family.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 922, pseudogene (RNU6-922P).